Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · IEX Real-Time Price · USD
6.03
+0.07 (1.17%)
May 2, 2024, 12:17 PM EDT - Market open
Nanobiotix Employees
Nanobiotix had 102 employees on December 31, 2023. The number of employees did not change compared to the previous year.
Employees
102
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$394,412
Profits / Employee
-$432,462
Market Cap
284.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 102 | 0 | - |
Dec 31, 2022 | 102 | 2 | 2.00% |
Dec 31, 2021 | 100 | 12 | 13.64% |
Dec 31, 2020 | 88 | -22 | -20.00% |
Dec 31, 2019 | 110 | 8 | 7.84% |
Dec 31, 2018 | 102 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
NBTX News
- 7 days ago - NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results - GlobeNewsWire
- 14 days ago - NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024 - GlobeNewsWire
- 4 weeks ago - Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation - GlobeNewsWire
- 2 months ago - Nanobiotix to Present at Upcoming Investor Conferences in March - GlobeNewsWire
- 3 months ago - Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference - GlobeNewsWire
- 3 months ago - Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study - GlobeNewsWire
- 6 months ago - NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update - GlobeNewsWire
- 6 months ago - NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023 - GlobeNewsWire